PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
1-Year Return
2.57%
This Quarter Return
+9.98%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.34B
AUM Growth
-$4.41M
(-0.33%)
Cap. Flow
-$45.9M
Cap. Flow
% of AUM
-3.43%
Top 10 Holdings %
Top 10 Hldgs %
67.32%
Holding
46
New
4
Increased
17
Reduced
9
Closed
3
Top Buys
| 1 |
Insmed
INSM
|
+$38.2M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$36.6M |
| 3 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
+$28.3M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$25.2M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$25.2M |
Top Sells
| 1 |
ITMN
INTERMUNE INC
ITMN
|
+$227M |
| 2 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
+$20.3M |
| 3 |
AGN
ALLERGAN INC
AGN
|
+$12.5M |
| 4 |
Amicus Therapeutics
FOLD
|
+$12M |
| 5 |
CYBX
CYBERONICS INC
CYBX
|
+$4.83M |
Sector Composition
| 1 | Healthcare | 56.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARIA
26
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $12.1M | 0.9% |
2,231,717
-43,886
| -2% | -$237K |
|
|
27
Amicus Therapeutics
FOLD
$2.46B
| $11.6M | 0.87% |
1,956,376
-2,015,200
| -51% | -$12M |
|
28
Align Technology
ALGN
$9.54B
| $11M | 0.82% |
213,100
+36,312
| +21% | +$1.88M |
|
29
Intuitive Surgical
ISRG
$161B
| $10.7M | 0.8% |
209,250
+43,650
| +26% | +$2.24M |
|
30
Rigel Pharmaceuticals
RIGL
$681M
| $10M | 0.75% |
518,010
| – | – |
|
31
Talphera
TLPH
$19.3M
| $8.91M | 0.67% |
+81,133
| New | +$8.91M |
|
|
QLTI
32
DELISTED
QLT Inc
QLTI
| $8.34M | 0.62% |
1,846,075
-41,133
| -2% | -$186K |
|
|
OREX
33
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $8.23M | 0.61% |
193,132
| – | – |
|
|
ZLTQ
34
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $6.43M | 0.48% |
+284,249
| New | +$6.43M |
|
35
Xoma
XOMA
$452M
| $2.63M | 0.2% |
31,245
| – | – |
|
36
Geron
GERN
$810M
| $2.32M | 0.17% |
1,161,400
-171,151
| -13% | -$342K |
|
|
HPTX
37
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $1.58M | 0.12% |
62,700
| – | – |
|
|
RVNC
38
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.55M | 0.12% |
80,369
-11,300
| -12% | -$218K |
|
|
BSTC
39
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $1.25M | 0.09% |
35,336
+24,152
| +216% | +$852K |
|
|
AVEO
40
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $1.06M | 0.08% |
95,803
-24,277
| -20% | -$269K |
|
|
SPHS
41
DELISTED
Sophiris Bio, Inc.
SPHS
| $858K | 0.06% |
292,900
| – | – |
|
42
Cytokinetics
CYTK
$6.12B
| $435K | 0.03% |
123,686
| – | – |
|
|
MNK
43
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $323K | 0.02% |
+3,588
| New | +$323K |
|
|
ITMN
44
DELISTED
INTERMUNE INC
ITMN
| – | – |
-5,134,058
| Closed | -$227M |
|
|
QCOR
45
DELISTED
QUESTCOR PHARMA INC
QCOR
| – | – |
-218,995
| Closed | -$20.3M |
|
|
AGN
46
DELISTED
ALLERGAN INC
AGN
| – | – |
-73,900
| Closed | -$12.5M |
|